ESG Commitment
Sustainability in Clinical Trials
As we work with our clients to improve health outcomes and lives, we are exploring ways to make clinical trials more sustainable, efficient, and accessible, for a better future.
Solving
site-level challenges
Streamlining operations at a site level reduces client work burden, waste and enhance trial efficiency, minimising overall environmental impact.
Global
Public health
Sustainable practices and increasing diversity in clinical research can address global health disparities, improving outcomes for all communities worldwide.
Investing in Communities
Investing in patient, professional, and partner communities along shared goals promotes sustainable practices that benefit both society and the environment.
For us, sustainability in clinical research isn't just about the environment. It's about creating better outcomes for patients, sponsors, and the communities we serve.
FutureMeds ESG Focus areas
We're identifying areas where we can make the most impact on our journey towards sustainability.
Talent
FutureMeds attracts professionals and partners who are passionate about patient outcomes at a local and global level. We invest in fostering a culture that enables our team to accomplish this goal.
Engaged committed teams
Strong professional purpose
Operational Efficiency
We're examining our processes to streamline logistics and operations to make better use of resources and reduce waste, improving both our and our clients’ environmental and business outcomes.
Sustainable trial delivery​
Futureproofed site model
Continuous Exploration
We're committed to ongoing exploration of new strategies to create a more sustainable future with our clients and partners for clinical research and the communities we serve.
Growing European influence
Long-term focus
Accelerating the adoption of DCTs in Europe
By promoting the use of hybrid and virtual trials, we increase access to diverse populations, improving trial efficiency, accelerating global health solutions, and promoting environmental sustainability.
Increased patient diversity and access
Enhanced contribution to medical progress
